Skip to main content
. Author manuscript; available in PMC: 2011 Jun 24.
Published in final edited form as: Cancer Biol Ther. 2010 Jun 24;9(12):1033–1042. doi: 10.4161/cbt.9.12.11876

Table 1.

Changes in expression of cholesterol biosynthesis and uptake genes and steroidogenic genes in cells acclimated to 1 nM testosterone exposure. The data are expressed as fold of change relative to the values in control cells. The numbers in bracket represent the range converted from the ΔΔCt values (mean ± SD).

Gene\Model VCaP LNCaP LAPC4
Cholesterol synthesis ACAT2 1.0 3.3 (3.1–3.4)** 2.1 (1.9–2.3)*
HMGCS1 − 1.1 2.1 (2.0–2.1)** 2.8 (2.7–2.9)**
HMGCR 1.6 1.9 2.1 (2.0–2.1)**
MVK 1.5 2.3 (1.9–2.6)* 2.4 (2.3–2.5)**
PMVK 1.6 2.1 (2.0–2.2)** 1.8
MVD 1.5 2.0 (1.9–2.0)** 2.6 (2.5–2.6)**
FDFT1 1.3 3.2 (3.1–3.3)** 2.4 (2.3–2.5)**
SQLE 1.9 1.7 2.1 (2.0–2.1)**
uptake Cholesterol SR-BI 1.5 4.0 (3.8–4.2)** 1.6
LDLR 1.6 2.5 (2.5–2.5)** 1.5
LOX1 9.0 (8.1–10.0) ** 1.5 1.9
SREC 4.7 (3.8–5.8) * 1.2 1.5
STAR 4.7 (3.9–5.6) ** 2.3 (2.1–2.4)** 1.8
steroidogenesis CYP11A1 8.2 (5.6–11.8) * 1.3 1.7
HSD3B2 3.9 (3.6–4.3) ** 1.2 1.9
CYP17A1 11.3(8.9–14.4)** 2.5 (2.4–2.6)** − 1.9
AKR1C3 − 1.3 − 1.3 6.9 (5.0–9.6)*
HSD17B3 3.1 (1.6–5.7) * 5.6 (2.8–11.0)* 1.8
SRD5A1 1.1 1.9 3.0 (2.8–3.3)**
SRD5A2 12.4(9.5–16.3)** 7.5 (5.2–10.8)* 1.0
SRD5A3 − 1.8 2.2 (2.0–2.3)** 1.6
AKR1C2 2.5 (2.3–2.8)** − 1.8 5.6 (3.5–8.8)*
RDH5 1.0 2.3 (2.1–2.5)** 1.3
*

p<0.05;

**

p<0.005, paired student’s t-test.